{"symbol": "DVAX", "companyName": "Dynavax Technologies Corporation", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.dynavax.com", "description": "Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (\"TLR\") stimulation.", "CEO": "Eddie Gray", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}